Literature DB >> 16845871

[Role of echo-colour Doppler in the diagnostic work-up and surgical timing of chronic venous insufficiency].

Marcello Donati1, Luigi Gandolfo, Santi Palmeri, Giovanna Brancato, Angelo Donati.   

Abstract

Chronic venous insufficiency affects about 10-12% to 35-50% of the population in industrialised countries. We analyse the role of echo-colour Doppler in the diagnostic-therapeutic work-up for this pathology in the light of their own experience. We report the results of the study of 158 legs in 79 patients, classifying the severity of chronic venous insufficiency using the Widmer classification, and private circulations using the Franceschi shunt classification. The mean duration of the examination was about 30 minutes (range: 22-46). A reflux time > 0.5 sec. was considered pathological. The patients with chronic venous insufficiency were divided into three groups on the basis of type of treatment: medical treatment and elastic compression (group 1,12 patients), sclerotherapy and elastic compression (group II, 20 patients), surgical treatment and sclerotherapy (group III, 36 patients). The echo-colour Doppler results were confirmed in the operating theatre in 34 patients. Echo-colour Doppler enabled us to identify patients who needed less invasive treatment than stripping; in group III, echo-colour Doppler allowed precise mapping and identification of communicant veins and collaterals, with 95% accuracy.

Entities:  

Mesh:

Year:  2006        PMID: 16845871

Source DB:  PubMed          Journal:  Chir Ital        ISSN: 0009-4773


  1 in total

1.  The Application of MEVEC 3D Doppler Ultrasound Technique for a New Classification of Morpho-Functional Phenotypes in Lower Limbs Venous Diseases.

Authors:  Aldo Innocente Galeandro; Cristina Galeandro; Pietro Scicchitano; Rosanna Clima; Ilenia Annunziata Ritacco; Massimiliano Dellisanti Fabiano Vilardi; Egidio Di Ponzio; Annamaria Annichiarico; Francesco Ciciarello; Vincenzo Contursi; Angelika Elzbieta Wegierska; Marco Matteo Ciccone
Journal:  Vasc Health Risk Manag       Date:  2022-02-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.